Compounding pharmacies worried about potentially excessive federal oversight in the wake of the deadly meningitis outbreak could adopt a private accreditation model in conjunction with state regulators in an effort to head off congressional action.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?